Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafia S Al-Lamki

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|May 3, 2014
Investigating the protective role of death receptor 3 (DR3) in renal injury using an organ culture modelRafia S Al-Lamki
Biomed Research International|December 19, 2013
Tumor necrosis factor receptor 2: its contribution to acute cellular rejection and clear cell renal carcinomaJun Wang, Rafia S Al-Lamki
Kidney International|August 21, 2014
TNF receptors: signaling pathways and contribution to renal dysfunctionRafia S Al-Lamki, Tanya N Mayadas
Frontiers in Medicine|September 29, 2017
Human Organ Culture: Updating the Approach to Bridge the Gap from <i>In Vitro</i> to <i>In Vivo</i> in Inflammation, Cancer, and Stem Cell BiologyRafia S Al-Lamki, John R Bradley, Jordan S Pober
Transplantation|November 27, 2008
Endothelial cells in allograft rejectionRafia S Al-Lamki, John R Bradley, Jordan S Pober
The Journal of Biological Chemistry|March 22, 2003
The a-subunit of the V-type H+-ATPase interacts with phosphofructokinase-1 in humansYa Su, Aiwu Zhou, Rafia S Al-Lamki, et al.
The American Journal of Pathology|March 29, 2005
Caveolae participate in tumor necrosis factor receptor 1 signaling and internalization in a human endothelial cell lineAlessio D'Alessio, Rafia S Al-Lamki, John R Bradley, et al.
The American Journal of Pathology|January 22, 2022
Co-Expression and Functional Interactions of Death Receptor 3 and E-Selectin in Clear Cell Renal Cell CarcinomaRafia S Al-Lamki, Jun Wang, Jordan S Pober, et al.
BMC Nephrology|November 17, 2014
TL1-A can engage death receptor-3 and activate NF-kappa B in endothelial cellsJun Wang, Rafia S Al-Lamki, Xinwang Zhu, et al.
FASEB Bioadvances|March 4, 2020
Tumor necrosis factor receptor-2 signaling pathways promote survival of cancer stem-like CD133<sup>+</sup> cells in clear cell renal carcinomaJohn R Bradley, Jun Wang, Simon Pacey, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Methods in Molecular Biology (Clifton, N.J.)|May 3, 2014
Investigating the protective role of death receptor 3 (DR3) in renal injury using an organ culture modelRafia S Al-Lamki
Biomed Research International|December 19, 2013
Tumor necrosis factor receptor 2: its contribution to acute cellular rejection and clear cell renal carcinomaJun Wang, Rafia S Al-Lamki
Kidney International|August 21, 2014
TNF receptors: signaling pathways and contribution to renal dysfunctionRafia S Al-Lamki, Tanya N Mayadas
Frontiers in Medicine|September 29, 2017
Human Organ Culture: Updating the Approach to Bridge the Gap from <i>In Vitro</i> to <i>In Vivo</i> in Inflammation, Cancer, and Stem Cell BiologyRafia S Al-Lamki, John R Bradley, Jordan S Pober
Transplantation|November 27, 2008
Endothelial cells in allograft rejectionRafia S Al-Lamki, John R Bradley, Jordan S Pober
The Journal of Biological Chemistry|March 22, 2003
The a-subunit of the V-type H+-ATPase interacts with phosphofructokinase-1 in humansYa Su, Aiwu Zhou, Rafia S Al-Lamki, et al.
The American Journal of Pathology|March 29, 2005
Caveolae participate in tumor necrosis factor receptor 1 signaling and internalization in a human endothelial cell lineAlessio D'Alessio, Rafia S Al-Lamki, John R Bradley, et al.
The American Journal of Pathology|January 22, 2022
Co-Expression and Functional Interactions of Death Receptor 3 and E-Selectin in Clear Cell Renal Cell CarcinomaRafia S Al-Lamki, Jun Wang, Jordan S Pober, et al.
BMC Nephrology|November 17, 2014
TL1-A can engage death receptor-3 and activate NF-kappa B in endothelial cellsJun Wang, Rafia S Al-Lamki, Xinwang Zhu, et al.
FASEB Bioadvances|March 4, 2020
Tumor necrosis factor receptor-2 signaling pathways promote survival of cancer stem-like CD133<sup>+</sup> cells in clear cell renal carcinomaJohn R Bradley, Jun Wang, Simon Pacey, et al.
Pageof 4